Literature DB >> 31860168

Biosensing in Smart Engineered Probiotics.

Austin G Rottinghaus1, Matthew B Amrofell1, Tae Seok Moon1,2.   

Abstract

Engineered microbes are exciting alternatives to current diagnostics and therapeutics. Researchers have developed a wide range of genetic tools and parts to engineer probiotic and commensal microbes. Among these tools and parts, biosensors allow the microbes to sense and record or to sense and respond to chemical and environmental signals in the body, enabling them to report on health conditions of the animal host and/or deliver therapeutics in a controlled manner. This review focuses on how biosensing is applied to engineer "smart" microbes for in vivo diagnostic, therapeutic, and biocontainment goals. Hurdles that need to be overcome when transitioning from high-throughput in vitro systems to low-throughput in vivo animal models, new technologies that can be implemented to alleviate this experimental gap, and areas where future advancements can be made to maximize the utility of biosensing for medical applications are also discussed. As technologies for engineering microbes continue to be developed, these engineered organisms will be used to address many medical challenges.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  biocontainment; biosensing; diagnostic; probiotic; therapeutic

Year:  2020        PMID: 31860168      PMCID: PMC7305048          DOI: 10.1002/biot.201900319

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  121 in total

1.  A microbial endocrinology-based simulated small intestinal medium for the evaluation of neurochemical production by gut microbiota.

Authors:  Daniel N Villageliú; Sharon Rasmussen; Mark Lyte
Journal:  FEMS Microbiol Ecol       Date:  2018-07-01       Impact factor: 4.194

Review 2.  Development of biosensors and their application in metabolic engineering.

Authors:  Jie Zhang; Michael K Jensen; Jay D Keasling
Journal:  Curr Opin Chem Biol       Date:  2015-06-05       Impact factor: 8.822

3.  Intrinsic biocontainment: multiplex genome safeguards combine transcriptional and recombinational control of essential yeast genes.

Authors:  Yizhi Cai; Neta Agmon; Woo Jin Choi; Alba Ubide; Giovanni Stracquadanio; Katrina Caravelli; Haiping Hao; Joel S Bader; Jef D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

5.  Short hairpin RNA-expressing bacteria elicit RNA interference in mammals.

Authors:  Shuanglin Xiang; Johannes Fruehauf; Chiang J Li
Journal:  Nat Biotechnol       Date:  2006-05-14       Impact factor: 54.908

6.  Biocontainment of genetically modified organisms by synthetic protein design.

Authors:  Daniel J Mandell; Marc J Lajoie; Michael T Mee; Ryo Takeuchi; Gleb Kuznetsov; Julie E Norville; Christopher J Gregg; Barry L Stoddard; George M Church
Journal:  Nature       Date:  2015-01-21       Impact factor: 49.962

7.  Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.

Authors:  Yunlei Zhang; Youming Zhang; Liqiu Xia; Xiangli Zhang; Xuezhi Ding; Fu Yan; Feng Wu
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

8.  Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria.

Authors:  Stefano Porzio; Paola Bossù; Paolo Ruggiero; Diana Boraschi; Aldo Tagliabue
Journal:  BMC Biotechnol       Date:  2004-10-30       Impact factor: 2.563

9.  The genetic basis of Escherichia coli pathoadaptation to macrophages.

Authors:  Migla Miskinyte; Ana Sousa; Ricardo S Ramiro; Jorge A Moura de Sousa; Jerzy Kotlinowski; Iris Caramalho; Sara Magalhães; Miguel P Soares; Isabel Gordo
Journal:  PLoS Pathog       Date:  2013-12-12       Impact factor: 6.823

10.  Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch.

Authors:  Benjamin L Oakes; Dana C Nadler; Avi Flamholz; Christof Fellmann; Brett T Staahl; Jennifer A Doudna; David F Savage
Journal:  Nat Biotechnol       Date:  2016-05-02       Impact factor: 54.908

View more
  5 in total

1.  Homologous Quorum Sensing Regulatory Circuit: A Dual-Input Genetic Controller for Modulating Quorum Sensing-Mediated Protein Expression in E. coli.

Authors:  Pricila Hauk; Kristina Stephens; Chelsea Virgile; Eric VanArsdale; Alex Eli Pottash; John S Schardt; Steven M Jay; Herman O Sintim; William E Bentley
Journal:  ACS Synth Biol       Date:  2020-09-15       Impact factor: 5.110

Review 2.  Engineering microbial diagnostics and therapeutics with smart control.

Authors:  Matthew B Amrofell; Austin G Rottinghaus; Tae Seok Moon
Journal:  Curr Opin Biotechnol       Date:  2020-06-18       Impact factor: 9.740

Review 3.  Microbial Biocontainment Systems for Clinical, Agricultural, and Industrial Applications.

Authors:  Aaron Pantoja Angles; Alexander U Valle-Pérez; Charlotte Hauser; Magdy M Mahfouz
Journal:  Front Bioeng Biotechnol       Date:  2022-02-02

4.  Bioactive peptides produced by engineered probiotics and other food-grade bacteria: A review.

Authors:  Haydee Eliza Romero-Luna; Adrián Hernández-Mendoza; Aarón Fernando González-Córdova; Audry Peredo-Lovillo
Journal:  Food Chem X       Date:  2021-12-22

5.  Genetically stable CRISPR-based kill switches for engineered microbes.

Authors:  Austin G Rottinghaus; Aura Ferreiro; Skye R S Fishbein; Gautam Dantas; Tae Seok Moon
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.